LncRNA: Shedding light on mechanisms and opportunities in fibrosis and aging.Fibrosis is universally observed in multiple aging-related diseases and progressions and is characterized by excess accumulation of the extracellular matrix.  In particular, the enigmatic class of long noncoding RNAs (lncRNAs) is a kind of noncoding RNA that is longer than 200 nucleotides and does not possess protein coding ability.  LncRNAs have been identified to exert both promotive and inhibitory effects on the multifaceted processes of fibrosis.  A growing body of studies has revealed that lncRNAs are involved in fibrosis in various organs, including the liver, heart, lung, and kidney.  As lncRNAs have been increasingly identified, they have become promising targets for anti-fibrosis therapies.  This review systematically highlights the recent advances regarding the roles of lncRNAs in fibrosis and sheds light on the use of lncRNAs as a potential treatment for fibrosis.
LncRNA
In particular, the enigmatic class of long noncoding RNAs (lncRNAs) is a kind of noncoding RNA that is longer than 200 nucleotides and does not possess protein coding ability.  LncRNAs have been identified to exert both promotive and inhibitory effects on the multifaceted processes of fibrosis.  A growing body of studies has revealed that lncRNAs are involved in fibrosis in various organs, including the liver, heart, lung, and kidney.  As lncRNAs have been increasingly identified, they have become promising targets for anti-fibrosis therapies.  This review systematically highlights the recent advances regarding the roles of lncRNAs in fibrosis and sheds light on the use of lncRNAs as a potential treatment for fibrosis.
lncRNAs
In particular, the enigmatic class of long noncoding RNAs (lncRNAs) is a kind of noncoding RNA that is longer than 200 nucleotides and does not possess protein coding ability.  LncRNAs have been identified to exert both promotive and inhibitory effects on the multifaceted processes of fibrosis.  A growing body of studies has revealed that lncRNAs are involved in fibrosis in various organs, including the liver, heart, lung, and kidney.  As lncRNAs have been increasingly identified, they have become promising targets for anti-fibrosis therapies.  This review systematically highlights the recent advances regarding the roles of lncRNAs in fibrosis and sheds light on the use of lncRNAs as a potential treatment for fibrosis.
lncRNAs
In particular, the enigmatic class of long noncoding RNAs (lncRNAs) is a kind of noncoding RNA that is longer than 200 nucleotides and does not possess protein coding ability.  LncRNAs have been identified to exert both promotive and inhibitory effects on the multifaceted processes of fibrosis.  A growing body of studies has revealed that lncRNAs are involved in fibrosis in various organs, including the liver, heart, lung, and kidney.  As lncRNAs have been increasingly identified, they have become promising targets for anti-fibrosis therapies.  This review systematically highlights the recent advances regarding the roles of lncRNAs in fibrosis and sheds light on the use of lncRNAs as a potential treatment for fibrosis.
lncRNAs
In particular, the enigmatic class of long noncoding RNAs (lncRNAs) is a kind of noncoding RNA that is longer than 200 nucleotides and does not possess protein coding ability.  LncRNAs have been identified to exert both promotive and inhibitory effects on the multifaceted processes of fibrosis.  A growing body of studies has revealed that lncRNAs are involved in fibrosis in various organs, including the liver, heart, lung, and kidney.  As lncRNAs have been increasingly identified, they have become promising targets for anti-fibrosis therapies.  This review systematically highlights the recent advances regarding the roles of lncRNAs in fibrosis and sheds light on the use of lncRNAs as a potential treatment for fibrosis.
lncRNAs